The Schall Law Firm Reminds Investors of Class Action Lawsuit Against SeaStar Medical Holding Corporation

Investor Alert: Are You Affected?

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 /

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation (“SeaStar” or “the Company”) (NASDAQ:ICU) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between October 31, 2022 and March 26, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before September 6, 2024.

The lawsuit alleges that SeaStar made false and/or misleading statements and/or failed to disclose that the Company experienced significant delays in its clinical trials, that they were not on track to meet the timelines laid out in their trial protocols, and that, as a result, SeaStar’s public statements were materially false and misleading at all relevant times.

Investors who purchased SeaStar’s securities during the Class Period may be eligible to seek compensation for any losses incurred. Contact The Schall Law Firm to learn more about your rights and options.

How Does This Affect Me?

If you are an investor who purchased SeaStar Medical Holding Corporation securities between October 31, 2022, and March 26, 2024, you may be affected by this class action lawsuit. It is important to stay informed about the developments in the case and consider seeking legal advice to protect your rights as an investor.

How Does This Affect the World?

This class action lawsuit against SeaStar Medical Holding Corporation highlights the importance of transparency and accountability in the financial markets. When companies mislead investors with false or incomplete information, it can have far-reaching consequences on the global economy. By holding companies accountable for their actions, investors can help promote a more ethical and trustworthy financial system for all stakeholders.

Conclusion

In conclusion, the class action lawsuit against SeaStar Medical Holding Corporation serves as a reminder for investors to stay vigilant and informed about their investments. By seeking legal advice and staying updated on the latest developments in this case, affected investors may be able to protect their rights and seek compensation for any losses incurred. Transparency and accountability are crucial in maintaining a fair and ethical financial market for all parties involved.